Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Graft vs Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07285889
What this trial is testing

First-Line Jaktinib for Acute Graft-Versus-Host Disease (aGVHD)

Who this might be right for
Acute Graft Versus Host Disease
First Affiliated Hospital of Zhejiang University 35
Not applicableNo Longer AvailableNCT03172455
What this trial is testing

Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Acute-graft-versus-host DiseaseSteroid Refractory Acute Graft Versus Host DiseaseGraft-versus-host-disease+5 more
Impatients N.V. trading as myTomorrows
Not applicableEnded earlyNCT01140984
What this trial is testing

Intra Arterial (IA) Steroids Infusion for Hepatic Acute Hepatic Graft Versus Host Disease (aGVHD)

Who this might be right for
Acute Graft Versus Host Disease
Hadassah Medical Organization 2
Not applicableStudy completedNCT02578225
What this trial is testing

Snapshot Evaluation of Acute and Chronic Heart Failure in Real Life in Turkey

Who this might be right for
Chronic Heart Failure
Prof. Dr. Mehmet Birhan Yılmaz 1,054
Testing effectiveness (Phase 2)Study completedNCT03847844
What this trial is testing

UCMSCs as Front-line Approach of Treatment for Patients With aGVHD

Who this might be right for
Acute-graft-versus-host Disease
Cytopeutics Sdn. Bhd. 26
Large-scale testing (Phase 3)Active Not RecruitingNCT05515029
What this trial is testing

Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With Hemoblastosis

Who this might be right for
Acute Lymphoblastic LeukemiaMyeloblastic LeukemiaBiphenotypic Acute Leukemia+3 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 56
Testing effectiveness (Phase 2)UnknownNCT00447460
What this trial is testing

Treatment of Refractory (Acute or Chronic) Graft-Versus-Host Disease by the Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem Cell

Who this might be right for
Graft-vs-Host Disease (GVHD)
University of Salamanca 15
Large-scale testing (Phase 3)Study completedNCT02336230
What this trial is testing

A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)

Who this might be right for
Grade B aGVHDGrade C aGVHDGrade D aGVHD
Mesoblast, Inc. 55
Testing effectiveness (Phase 2)WithdrawnNCT01882387
What this trial is testing

Efficacy Study of a TXA127 to Reduce Graft-vs-Host Disease in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
Hematologic Malignancies
Tarix Pharmaceuticals
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07381114
What this trial is testing

A Clinical Study on the Efficacy and Safety of Ivarmacitinib in Preventing aGVHD After HLA-matched Transplantation

Who this might be right for
aGVHD
Institute of Hematology & Blood Diseases Hospital, China 32
Testing effectiveness (Phase 2)Ended earlyNCT01453140
What this trial is testing

In-vivo Regulatory T Cell Enhancement With Cyclophosphamide and Sirolimus

Who this might be right for
Graft Versus Host Disease
Hackensack Meridian Health 3
Testing effectiveness (Phase 2)Study completedNCT00078858
What this trial is testing

Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+132 more
Fred Hutchinson Cancer Center 37
Testing effectiveness (Phase 2)Study completedNCT00002833
What this trial is testing

Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
M.D. Anderson Cancer Center 53
Not applicableLooking for participantsNCT05315726
What this trial is testing

The Effects of Muscle Vibration on the Development of Spasticity and Neuroplasticity in a Post-stroke Population

Who this might be right for
Post-stroke Patient in Acute, Sub-acute Phase or Chronic
Centre Hospitalier Universitaire Dijon 165
Not applicableStudy completedNCT01463475
What this trial is testing

University of Wisconsin hMSC Cell Bank: Bone Marrow Donor Protocol

Who this might be right for
Graft Versus Host Disease (GVHD)Acute Myocardial Infarction (AMI)
University of Wisconsin, Madison 3
Early research (Phase 1)Study completedNCT00001748
What this trial is testing

HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies

Who this might be right for
Graft vs Host DiseaseHematologic NeoplasmsLymphoma+2 more
National Heart, Lung, and Blood Institute (NHLBI) 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07819396
What this trial is testing

Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Biphenotypic LeukemiaAcute LeukemiaAcute Leukemia of Ambiguous Lineage+11 more
Fred Hutchinson Cancer Center 52
Testing effectiveness (Phase 2)Study completedNCT02500550
What this trial is testing

Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Kiadis Pharma 15
Not applicableLooking for participantsNCT04745221
What this trial is testing

Efficacy and Safety of Auto-FMT in Preventing aGVHD

Who this might be right for
Graft Versus Host Disease, Acute
The First Affiliated Hospital of Soochow University 100
Not applicableUnknownNCT00093587
What this trial is testing

Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Who this might be right for
Graft Versus Host DiseaseLeukemia
Jonsson Comprehensive Cancer Center
Next Page